Answers are grounded in this paper and cite their sources.
Introduction Despite optimal medical therapy (OMT), patients with HFrEF may remain symptomatic leading to increased hospitalisation or death. The European Society of Cardiology guidelines for heart failure recommend cardiac resynchronisation therapy (CRT) and/or implantable cardiac defibrillators (ICD) in patients with persisting left ventricular function impairment and/or are symptomatic despite optimal medical therapy. We hypothesise that during complex device implant, right heart catheterization is feasible and could identify patients at higher risk of heart failure decompensation. Methods 17 patients with HFrEF on OMT (mean age 62+8 years, 12% female and 29% non-ischaemic cardiomyopathy), admitted electively for an ICD or CRT implantation at Morriston Cardiac Centre, Swansea, UK underwent right heart pressure measurement during the procedure. The patient was consented for ICD or CRT implant and additionally for a right heart catheterisation during device implantation. Axillary, cephalic or subclavian vein access was gained and the right ventricular (RV) lead was implanted and fixed. A SafeSheathTM (Pressure Products) was inserted. A balloon catheter was then inserted and used to measure mean right atrial (mRAP), mean RV, mean pulmonary artery pressure (mPAP) and mean pulmonary capillary wedge pressure (mPCWP). The balloon catheter was then removed. The left ventricular lead and atrial lead were then implanted and fixed. The ICD/CRT device was then implanted and the wound closed with absorbable sutures. Results All but 2 patients were on OMT due to brady-arrhythmia. The mRAP was 5+3 mmHg, mRVP was 27+11 mmHg, mPAP was 17+ 8 mmHg and mPCWP was 10+7 mmHg. 13 (76%) patients had normal mPAP (<20 mmHg), 1 (5.8%) had mPAP between 20–25 mmHg and 3 (17.6%) patients had elevated mPAP >25 mmHg. Right heart pressure measuremments did not significantly prolong procedure time with a mean procedure length of 101+35 minutes for CRT implantation and 64+42 minutes for ICD. Of the 3 patients with mPAP >25 mmHg, 2 had an increase in diuretic therapy as a result, which was well tolerated. There were no peri-procedural or post-procedural complications. One patient had a device related infection, which necessitate device extraction and subsequent contralateral re-implantation. Conclusions Elevated pressures during ICD/CRT implantation may identify patients at a higher risk of heart failure related events and prompt closer follow up. Conflict of Interest Nil
No takes yet. Share an insight, caveat, or question.
Jeffery et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: